{"id":"W2132550116","doi":"10.1093/annonc/mdf195","title":"Neovastat (Æ-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels","year":2002,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":false,"ca_institutions":"BP (Canada); McGill University","funders":"","keywords":"Medicine; Refractory (planetary science); Renal cell carcinoma; Adverse effect; Internal medicine; Toxicity; Clinical trial; Cancer; Gastroenterology; Oncology; Carcinoma; Urology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000310096,0.0001630432,0.0004619179,0.0001104557,0.00003063431,0.000002563537,0.0001546232,0.000178478,0.00009712637],"category_scores_gemma":[0.0001105096,0.000144977,0.000127689,0.0001256421,0.0001731204,0.000008638166,0.00008319815,0.0001244315,0.000001417076],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001520619,"about_ca_system_score_gemma":0.0002419711,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002066042,"about_ca_topic_score_gemma":0.0002338856,"domain_scores_codex":[0.9984671,0.0001234957,0.0006070157,0.0003484525,0.0001655914,0.0002883236],"domain_scores_gemma":[0.9987118,0.00002449818,0.0004968696,0.0003969945,0.00027963,0.00009024893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.06039876,0.01643705,0.003115878,0.00010676,0.0001986785,0.00005444359,0.001581992,0.00006602959,0.6142992,0.00004522098,0.1511468,0.1525491],"study_design_scores_gemma":[0.07954429,0.02920082,0.002081661,0.00001552544,0.00004337269,0.0000337315,0.00006300776,0.000007223806,0.09546809,0.00002195076,0.7932918,0.0002285148],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920631,0.00103228,0.00002652785,0.0001608562,0.001390045,0.0003329875,0.00006801994,0.00000351533,0.00492269],"genre_scores_gemma":[0.9960956,0.000287641,0.0002505361,0.0002836043,0.002059315,0.0000300749,0.0000727148,0.00001851061,0.0009020354],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.642145,"threshold_uncertainty_score":0.5911989,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05781564707740489,"score_gpt":0.3455197344821135,"score_spread":0.2877040874047087,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}